Search research articles
Contact Us
Filters
Showing results (91-100 of 154) with videos related to
Page
of 16
Sort By:
Biochimica Et Biophysica Acta
|
December 14, 2011
The immunological contribution of NF-κB within the tumor microenvironment: a potential protective role of zinc as an anti-tumor agent
Bin Bao, Archana Thakur, Yiwei Li, et al.
Cancer Metastasis Reviews
|
September 9, 2021
Targeting KRAS in pancreatic cancer: new drugs on the horizon
Sahar F Bannoura, Md Hafiz Uddin, Misako Nagasaka, et al.
Molecular Cancer Therapeutics
|
January 8, 2017
Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma
Amro Aboukameel, Irfana Muqbil, William Senapedis, et al.
Current Oncology (Toronto, Ont.)
|
November 24, 2022
Thymoquinone Plus Immunotherapy in Extra-Pulmonary Neuroendocrine Carcinoma: Case Series for a Novel Combination
Amr Mohamed, Asfar S Azmi, Sylvia L Asa, et al.
Cancer Research
|
November 24, 2011
Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression
Bin Bao, Shadan Ali, Sanjeev Banerjee, et al.
Signal Transduction and Targeted Therapy
|
November 27, 2025
Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges
Khalil Choucair, Hafsa Imtiaz, Md Hafiz Uddin, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 17, 2011
Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells
Bin Bao, Zhiwei Wang, Shadan Ali, et al.
Stem Cells and Development
|
April 17, 2014
Differentially expressed miRNAs in cancer-stem-like cells: markers for tumor cell aggressiveness of pancreatic cancer
Bin Bao, Shadan Ali, Aamir Ahmad, et al.
Plos One
|
December 29, 2012
Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment
Bin Bao, Shadan Ali, Aamir Ahmad, et al.
Oncotarget
|
November 16, 2017
Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration
Asfar S Azmi, Yiwei Li, Irfana Muqbil, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 154) with videos related to
Sort By:
Page
of 16
Biochimica Et Biophysica Acta
|
December 14, 2011
The immunological contribution of NF-κB within the tumor microenvironment: a potential protective role of zinc as an anti-tumor agent
Bin Bao, Archana Thakur, Yiwei Li, et al.
Cancer Metastasis Reviews
|
September 9, 2021
Targeting KRAS in pancreatic cancer: new drugs on the horizon
Sahar F Bannoura, Md Hafiz Uddin, Misako Nagasaka, et al.
Molecular Cancer Therapeutics
|
January 8, 2017
Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma
Amro Aboukameel, Irfana Muqbil, William Senapedis, et al.
Current Oncology (Toronto, Ont.)
|
November 24, 2022
Thymoquinone Plus Immunotherapy in Extra-Pulmonary Neuroendocrine Carcinoma: Case Series for a Novel Combination
Amr Mohamed, Asfar S Azmi, Sylvia L Asa, et al.
Cancer Research
|
November 24, 2011
Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression
Bin Bao, Shadan Ali, Sanjeev Banerjee, et al.
Signal Transduction and Targeted Therapy
|
November 27, 2025
Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges
Khalil Choucair, Hafsa Imtiaz, Md Hafiz Uddin, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 17, 2011
Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells
Bin Bao, Zhiwei Wang, Shadan Ali, et al.
Stem Cells and Development
|
April 17, 2014
Differentially expressed miRNAs in cancer-stem-like cells: markers for tumor cell aggressiveness of pancreatic cancer
Bin Bao, Shadan Ali, Aamir Ahmad, et al.
Plos One
|
December 29, 2012
Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment
Bin Bao, Shadan Ali, Aamir Ahmad, et al.
Oncotarget
|
November 16, 2017
Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration
Asfar S Azmi, Yiwei Li, Irfana Muqbil, et al.
Page
of 16